Arboretum Ventures

Founded 2002
Founders Jan Garfinkle Tim Petersen


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 82
Average round size
The average size of a deal this fund participated in
Portfolio companies 50
Rounds per year 4.32
Lead investments 12
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 20
Key employees 4
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Pharmaceutical

Arboretum Ventures is the famous VC, which was founded in 2002. The venture was found in North America in United States. The main office of represented VC is situated in the Ann Arbor.

The current fund was established by Jan Garfinkle, Tim Petersen. We also calculated 4 valuable employees in our database.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Arboretum Ventures, startups are often financed by Chrysalis Ventures, Lumira Ventures, ONSET Ventures. The meaningful sponsors for the fund in investment in the same round are Chrysalis Ventures, Baird Capital, ONSET Ventures. In the next rounds fund is usually obtained by Lumira Ventures, ONSET Ventures, Flagship Pioneering.

The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 2-6 deals every year. The increased amount of exits for fund were in 2018. Considering the real fund results, this VC is 15 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Arboretum Ventures performs on 9 percentage points less the average number of lead investments. The important activity for fund was in 2013. Despite it in 2019 the fund had an activity.

Among the most successful fund investment fields, there are Medical, Hospital. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager. Among the most popular portfolio startups of the fund, we may highlight Cardiac Dimensions, NeuMoDx Molecular, Delphinus Medical Technologies.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Convergent Dental

Health Care
Medical Device
$40M29 Oct 2021 Massachusetts, United States

Akadeum Life Sciences

Information Technology
$17M12 Oct 2021 Ann Arbor, Michigan, United States

Allay Therapeutics

$60M15 Sep 2021 Menlo Park, California, United States


Health Care
Health Diagnostics
Medical Device
$24M09 Sep 2021 Seattle, Washington, United States

Navv Systems

Health Care
$3M06 Jun 2021 Detroit, Michigan, United States


Health Care
Medical Device
$14M02 Feb 2021 Greater Sudbury, Ontario, Canada

Jumpcode Genomics

Health Care
$21M20 Jan 2021 Carlsbad, California, United States


Health Care
$500M11 Jan 2021 Cambridge, Massachusetts, United States

$80M08 Dec 2020 Boston, Massachusetts, United States
Convergent Dental Raises $40M in Series C Funding

– Convergent Dental, a Needham, MA-based developer of a laser to enable anesthesia-free, pain-free dentistry, raised $40m in Series C round.
– The round was led by Arboretum Ventures, with participation from existing investors, including Long River Ventures and the Gund Foundation.
– The new investment will be used to expand the company’s product portfolio and increase investment in market development.

Francis Medical Raises $55M in Series B Equity Funding

– Francis Medical, a Minneapolis MI-based medical device company, raised $55M in Series B equity funding.
– The round was led by Solas BioVentures with participation from Arboretum Ventures, Coloplast A/S, H2Oey Ventures and Tonkawa.
– The company intends to use the funds to fund for the development of its proprietary prostate cancer treatment through FDA 510(k) approval, which includes a pivotal clinical study (VAPOR 2) for the management of prostate cancer.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Arboretum Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: